(2731 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Management of ocular allergyAbstract The treatment and management of ocular allergy (OA) remain a major concern for d...
-
The One Health approach for allergic diseases and asthmaAbstract The One Health approach is a collaborative and interdisciplinary strategy with f...
-
Exercise and physical activity for asthma management: The European Academy of Allergy and Clinical Immunology perspectiveAsthma is a complex heterogeneous disease characterized by bronchial hyperresponsiveness (...
-
Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseasesAbstract Allergic diseases of the (upper and lower) airways, the skin and the gastrointes...
-
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivityAbstract Drug hypersensitivity reactions (DHRs) are common, and the skin is by far the mo...
-
Delayed hypersensitivity to antiepileptic drugs in childrenAbstract Background: Antiepileptic drugs (AEDs) are widely used for the treatment of ep...
-
Allergies and COVID-19 vaccines: An ENDA/ EAACI Position paperAbstract Background: Anaphylaxis, which is rare, has been reported after COVID-19 vacci...
-
Practice parameters for diagnosing and managing iodinated contrast media hypersensitivityAbstract Immediate and nonimmediate hypersensitivity reactions to iodinated contrast medi...
-
A multi-disciplinary approach to the diagnosis and management of allergic disease: An EAACI Task ForceAbstract Background: Guidelines for management of patients with allergic conditions are...
-
Diagnosis and management of drug-induced anaphylaxis in children: An EAACI position paperAbstract Drug hypersensitivity reactions (DHR) constitute a major and common public healt...
-
EAACI Position paper on the standardization of nasal allergen challengesAbstract Nasal allergen challenge (NAC) is an important tool to diagnose allergic rhiniti...
-
Respiratory diseases and allergy in farmers working with livestock: a EAACI position paperAbstract Farmers constitute a large professional group worldwide. In developed countries ...
-
Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergyAbstract Humans inhale, ingest, and touch thousands of fungi each day. The ubiquity and d...
-
EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research prioritiesAbstract Allergic asthma (AA) is a common asthma phenotype, and its diagnosis requires bo...
-
Diagnosis and management of allergy and respiratory disorders in sport: An EAACI task force position paperAbstract Allergy and respiratory disorders are common in young athletic individuals. In t...
-
Technical standards in allergen exposure chambers worldwide - an EAACI Task Force ReportAbstract Allergen exposure chambers (AECs) can be used for controlled exposure to allerge...
-
Hypersensitivity reactions to chemotherapy: an EAACI position paperAbstract Chemotherapeutic drugs have been widely used in the treatment of cancer disease ...
-
Hypersensitivity reactions to biological agents: An EAACI position paperAbstract Biologicals are crucial targeted therapeutic agents in oncological, immunologica...
-
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancerAbstract While desired for the cure of allergy, regulatory immune cell subsets and noncla...
-
Diagnosis and management of Non-IgE gastrointestinal allergies in breastfed infants - An EAACI Position PaperAbstract It is well-established that food proteins, such as egg, soya, cow’s milk a...
-
Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paperAbstract A recent survey of the European Academy of Allergy and Clinical Immunology (EAAC...
-
A European survey of management approaches in chronic urticaria in children: EAACI Paediatric Urticaria TaskforceAbstract Background: Although well described in adults, there are scarce and heterogene...
-
Biologicals in atopic disease in pregnancy: An EAACI position paperAbstract Biologicals have transformed the management of severe disease phenotypes in asth...
-
Management of anaphylaxis due to COVID-19 vaccines in the elderlyAbstract Older adults, especially men and/or those with diabetes, hypertension, and/or ob...
-
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statementAbstractThe current COVID-19 pandemic influences many aspects of personal and social in-te...
-
Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implicationsAbstract Innate lymphoid cells (ILC) represent a group of lymphocytes that lack specific ...
-
Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall documentAbstract Exposome research can improve the understanding of the mechanistic connections b...
-
Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position PaperAbstract Currently available European Alpine Altitude Climate Treatment (AACT) programs co...
-
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD) - a EAACI position paperAbstract NSAID-exacerbated respiratory disease (N-ERD) is a chronic eosinophilic, inflamm...
-
Cannabis-related allergies: an international overview and consensus recommendationsAbstract Cannabis is the most widely used recreational drug in the world. Cannabis sativa ...
-
Allergic and hypersensitivity conditions in non-specialist care: Flow diagrams to support clinical practiceAbstract Most patients presenting with allergies are first seen by primary care health pr...
-
Diagnosis and management of food allergy-associated gastroesophageal reflux disease in young children - EAACI position paperAbstract Gastro-oesophageal reflux (GOR) and food allergy (FA) are common conditions, esp...
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccinesAbstract The first approved COVID-19 vaccines include Pfizer/BioNTech BNT162B2, Moderna m...
-
Gender and occupational allergy: Report from the task force of the EAACI Environmental and Occupational Allergy Interest GroupAbstract Women’s work has traditionally been considered less hazardous to health in...
-
Health effects of exposure to chlorination by - products in swimming poolsAbstract Concerns have been raised regarding the potential negative effects on human heal...
-
Preliminary pilot study results of the EAACI allergy educational needs in primary care pediatricians Task Force in managing allergic disordersREAD HERE
-
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statementAbstract The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pande...
-
Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review - An EAACI position paperAbstract Drug hypersensitivity reactions (DHRs) are associated with high global morbidity...
-
An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactionsAbstract Perioperative immediate hypersensitivity reactions are rare. Subsequent allergy ...
-
Current allergy educational needs in primary care. Results of the EAACI working group on primary care survey exploring the confidence to manage and the opportunity to refer patients with allergyAbstract The aim of this survey was to explore the specific educational needs of a cohort...
-
A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paperAbstract Introduction: Adolescence is a critical stage of rapid biological, emotional a...
-
Omics technologies in allergy and asthma research: An EAACI position paperAbstract Allergic diseases and asthma are heterogenous chronic inflammatory conditions wit...
-
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapyAbstract Purpose: The European Academy of Allergy and Clinical Immunology (EAACI) has p...
-
Toward clinically applicable biomarkers for asthma: An EAACI position paperAbstract Inflammation, structural, and functional abnormalities within the airways are ke...
-
AllergoOncology: Microbiota in allergy and cancer - A European Academy for Allergy and Clinical Immunology position paperAbstract The microbiota can play important roles in the development of human immunity and...
-
EAACI position paper: Comparing insect hypersensitivity induced by bite, sting, inhalation or ingestion in human beings and animalsAbstract Adverse reactions to insects occur in both human and veterinary patients. System...
-
Dangerous liaisons: bacteria, antimicrobial therapies and allergic diseasesAbstract Microbiota composition and associated metabolic activities are essential for the...
-
EAACI Research and Outreach Committee: Improving standards and facilitating global collaboration through a Research Excellence NetworkAllergy, Asthma and Clinical Immunology Research has many challenges, including complex Eu...
-
Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position PaperAbstract Multisystem inflammatory syndrome in children (MIS-C) is a rare, but severe comp...
-
The development of birch pollen seasons over 30 years in Munich, Germany - An EAACI task force reportThe global warming–oriented climate change is able to induce changes in the presentation...
-
Placebo effects in allergen immunotherapy - An EAACI Task Force Position PaperAbstract The placebo (Latin “I will please”) effect commonly occurs in clinic...
-
Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19: An EAACI position paperAbstract Coronavirus disease 2019 (COVID-19), a respiratory tract infection caused by a n...
-
Allergen immunotherapy in people, dogs, cats and horses – differences, similarities and research needsAbstract In human patients with seasonal allergic rhinoconjunctivitis sensitized to grass...
-
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)An ARIA-EAACI statement has been devised to make recommendations on asthma, and not necess...
-
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statementA novel strain of human coronaviruses, named by the International Committee on Taxonomy of...
-
EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescentsAbstract Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used in the pediatri...
-
Influenza burden, prevention, and treatment in asthma - A scoping review by the EAACI Influenza in asthma task forceAbstract To address uncertainties in the prevention and management of influenza in people...
-
An EAACI Task Force report on allergy to beta-lactams in children: Clinical entities and diagnostic proceduresAbstract Beta-lactam (BL) allergy suspicion is common in children and constitutes a major...
-
The roadmap for allergology in Europe: The subspecialty of allergology as “stop-over” on the way to a full specialty. An EAACI position statementAbstract The vision of European Academy of Allergy and Clinical Immunology (EAACI) and th...
-
The roadmap for the Allergology specialty and allergy care in Europe and adjacent countries. An EAACI position paperAbstract The high prevalence of allergic diseases warrants for sufficient health care pro...
-
Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence"Abstract Background: Although there is a considerable body of knowledge about allergen ...
-
One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-CoV-2Abstract The latest outbreak of a coronavirus disease in 2019 (COVID-19) caused by the se...
-
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paperAbstract Because of the inflammatory mechanisms of most chronic upper airway diseases suc...
-
Pollen season is reflected on symptom load for grass and birch pollen-induced allergic rhinitis in different geographic areas - An EAACI Task Force ReportAbstract Background: The effectiveness of allergen immunotherapy (AIT) in seasonal and ...
-
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paperAbstract Chronic airway diseases such as asthma and chronic obstructive pulmonary disease...
-
Skin microdialysis: methods, applications and future opportunities - an EAACI position paperAbstract Skin microdialysis (SMD) is a versatile sampling technique that can be used to r...
-
Allergy to stings and bites from rare or locally important arthropods: Worldwide distribution, available diagnostics and treatmentAbstract Insect venom allergy is the most frequent cause of anaphylaxis in Europe and poss...
-
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposisAbstract Nasal endoscopy is not only used for the diagnosis of chronic rhinosinusitis wit...
-
Prioritizing research challenges and funding for allergy and asthma and the need for translational research - The European Strategic Forum on Allergic DiseasesAbstract The European Academy of Allergy and Clinical Immunology (EAACI) organized the fi...
-
In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan - An EAACI position paperAbstract Diagnostic allergens are defined as medicinal products in the EU. Marketing auth...
-
Perceptions of adolescents and young adults with allergy and/ or asthma and their parents on EAACI guideline recommendations about transitional care: A European surveyAbstract Background: The European Academy of Allergy and Clinical Immunology has develo...
-
State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)Abstract Since the introduction of allergen immunotherapy (AIT) over 100 years ago, focus...
-
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paperAbstract Background: Chronic rhinosinusitis is regarded as a chronic airway disease. Acc...
-
The role of mobile health technologies in allergy care: An EAACI position paperAbstract Mobile health (mHealth) uses mobile communication devices such as smartphones an...
Show more Position Papers (72)Show Less-
-
Exercise: induced asthma and rhinitis
-
AAAAI Practice Parameters
-
Risk assessment and active management of food allergy
-
Bronchiectasis and severe asthma
-
Asma e alergia em Angola
-
Asthma management during the COVID-19 pandemics
-
Updates in [severe] asthma in adults
-
Exercise-induced urticaria and anaphylaxis
-
Precision medicine in immunodeficiency
-
Virtual care, social media and mHealth for allergy management
-
Precision Medicine and AIT
-
Severe Asthma and COVID-19
-
Neuroimmunology and allergy
-
New perspectives for anaphylaxis
-
Asma e alergia em pandemia
-
Novel pharamacological targets
-
Danger signs
-
Novel cell based assays in allergy diagnostics
-
Big changes in asthma treatment : GINA 2019
-
May contain traces… management in children with food allergies
-
Food allergy: new allergens on the block
-
Eosinophilic fasciitis, an unusual presentation
-
Tezepelumab (anti-TSLP) in asthma
-
Precision medicine and biomarkers of atopic dermatitis
-
Management of adverse reactions to biologics
-
Measles infection causes immune amnesia
-
Potential biomarkers for diagnosis and treatment for CSU
-
Implementation of telehealth in asthma management: trials and tribulations
-
When to suspect allergic contact dermatitis in atopic dermatitis patients
-
Drug reactions of the skin or Novel mechanisms of drug reactions
-
Moisturisers for the primary prevention of food allergy
-
Immunotherapy in severe asthma (AIT)
-
Elderly asthma
-
Management of CRS: Highlights of EPOS 2020
-
Management of CRS: Highlights of EPOS 2020
-
Elevated tryptase – Now what?
-
Getting the diagnosis right is essential for optimal nutritional and dietary management of food allergy
-
Developing an adolescent and young adult allergy service
-
Epithelial cell barrier and allergic diseases
-
Sleep patterns and development of children with atopic dermatitis
-
Hologenome and obesity
-
Collective advocacy for action on CRDs
-
How to improve compliance of allergen immunotherapy in the clinic?
-
New and clinically relevant contact allergens
-
Asthma endotypes as risk factors for severe COVID-19 manifestations
-
Airborne enzymes – New and re-emerging occupational hazards
-
Practical approach of diagnosis and management of not IgE mediated food allergies
-
Tackling anaphylaxis
-
Gaps in the management of food-induced anaphylaxis reactions at school
-
Biologicals in allergy and asthma: A deep learning approach to optimized patient management
-
How to improve outcomes
-
Can the birch pollen be more aggressive in the polluted environments?
-
Primary care in CRDs during COVID
-
Late onset T2 asthma – a case study
-
The role of metalloproteinase 9 in the pathogenesis of atopic dermatitis in children
-
How do allergens sensitize?
-
Global impact of the COVID-19 on the environment
-
Immune response to Corona virus infection
-
Predicting adverse reactions to biologicals
-
Electronic Health in Severe Asthma
-
Route of exposure determines the immune response to food allergens
-
New insights in urticaria mechanisms
-
How to classify cutaneous manifestations of drug hypersensitivity
-
Hypersensitivity to antiepileptic drugs
-
Epitope mapping of the major allergen 2S albumin from pine nut
-
Nasal allergen challenge
-
Update of the WAO anaphylaxis guidance
-
Impact of climate change on the immune system
-
Delabelling adults
-
Differential diagnosis
-
Precision Medicine and integrated care pathways in 2020 and beyond
-
What do we learn from subgroup analyses in phase-III trials?
-
Early life wheeze - risk factors for asthma in school age
-
Is anaphylaxis really rare in children?
-
Telemedicine and Tele-health
-
Immunological basis of food aversion
-
Desensitization in chemotherapy and biologics
-
Novel insight into development of allergic diseases
-
Big Data Analysis: MetabolomicsView Presentation
-
Impact of climate change on asthma exacerbations
-
Evidence of immunotherapy on allergy prevention?
-
Food industry perspective
-
Autoimmunity in atopic diseases
-
Large spectrum response to Dupilumab in a patient with atopic multimorbidity
-
Severe cutaneous allergic reactions: searching for the culprit drug
-
E-cigarettes: mechanistic link to lung injury
-
Wild-fires, pollution, climate change and other threats
-
An update on prevention of allergic diseases
-
Social media and Allergies: how can we support our patients?
-
Update on drug allergy
-
Over-the-counter allergy prevention weaning products
-
Asthma: phenotypes to endotypes
-
AI models
-
Understanding parent preferences for paediatric allergy services
-
Mechanisms of non IgE mediated food allergy
-
How to keep a child with anaphylaxis safe in school
-
Bronchial allergen challenge in the clinic
-
Food allergy - the beginners guide
-
Big data and cluster analysis: a real life perspective
-
Novel approaches of allergen immunotherapy
-
Skin care from birth for allergy prevention: results today
-
Beyond first line therapies for recalcitrant allergic diseases: Asthma
-
Challenges on the implementation of early introduction of allergenic foods
-
A system biology and machine learning approach to childhood asthma
-
Viral infection and asthma
-
Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study
-
A patient with an acute reaction: recognize, document and treat
-
Pediatric Covid-19 highlights published in PAI in 2020
-
Probiotics and prebiotics: an on-going journey
-
Biological severe asthma treatment in Poland - pros and cons of drug programme
-
Focus on Patient. Personalised therapy for severe asthma
-
Therapies for multiple-tree nut allergies
-
Algorithm for evaluation of cutaneous manifestations of drug hypersensitivities
-
Should we use partial allergen sequence information for food allergy risk assessment?
-
Role of antigen-presenting cells in tolerance and allergy
-
Diagnosis of insect venom allergy: back to basics
-
Role Viral reactivations
-
Is There A Place For Chlorhexidine In The European Baseline Series?
-
Bacterial lysates in asthma treatment in children / Lizaty bakteryjne w astmie u dzieci.
-
Placeebo effect is an integrated part of the treatment of AIT (Pro & Con Session: Con)
-
Cellular tests for the diagnosing and monitoring of allergy
-
Lessons learned from immune tolerance approaches to target allergic diseases: an NIAD’s perspective
-
Hypereosinophilic syndromes and autoimmunity
-
Does human milk and its composition matter for development and prevention of allergies?
-
Alergia molecular na seleção de extratos para imunoterapia aos ácaros
-
Air pollution and allergy: call for action!
-
An update on food allergy
-
Sustained unresponsiveness to tree nuts after low dose oral immunotherapy in children aged 9-24 months
-
Alternaria-induced thunderstorm asthma: An unrecognised trigger
-
Differences in epitome response in peanut-allergic subjects treated with different immunotherapy preparations
-
Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis
-
The underlying immunology of pruritus
-
Paediatric multisystem allergy: a new diagnostic and severity score
-
Vaccines for older adults: benefits and limitations
-
Precision medicine and biomarkers in chronic rhinosinusitis with nasal polyps
-
New visions for managing anaphylaxis. Lesson from EAACI guidelines
-
Worldwide survey shows that atopic dermatitis is associated with a high disease burden in adolescents
-
ÖGAI: Covid as best practice model to combine immunology and allergy
-
Preparing a grant: Dos and Don'ts
-
Contraindications to venom immunotherapy and risk factors for adverse events: any left?
-
Molecular immune biomarkers for protein-based and peptide immunotherapy
-
Exposome modulation and immunotherapy in infants at higher risk of respiratory allergies
-
Vaccines- Is this the tool to end the pandemic?
-
Lung function testing
-
Dupilumab in paediatric patients with eosinophilic esophagitis
-
Lesson learned from the pathogenesis of SARS-COV2
-
